证券记录 · 已归档季度
ALGN
Align Technology, Inc. · Healthcare · Medical - Devices
19被追踪持有人
-1Δ持有人
27.12M持有股份
$5.13B报告持仓市值
+1新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -5.0% ·
股份流向 -0.5% ·
净新建仓位 -5.3%
· 公式
广泛减持：持股数量下降，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 3.13M | $454.47M | n/a | −2 |
| Q2 2026 | 152 | -2 | 56.51M | $9.53B | +4 | −7 |
| Q1 2026 | 158 | -3 | 53.10M | $9.09B | +1 | −5 |
| Q4 2025 | 160 | -1 | 51.76M | $8.08B | +1 | −1 |
| Q3 2025 | 23 | +2 | 27.57M | $3.45B | +3 | −2 |
| Q2 2025 | 19 | -1 | 27.12M | $5.13B | +1 | −2 |
| Q1 2025 | 17 | 0 | 12.53M | $1.99B | +2 | −2 |
| Q4 2024 | 17 | 0 | 12.70M | $2.65B | n/a | n/a |
| Q3 2024 | 16 | -2 | 10.06M | $2.56B | n/a | −2 |
| Q2 2024 | 18 | n/a | 8.21M | $1.98B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 8.24M | n/a | $1.56B | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 5.13M | n/a | $970.74M | 0.0% | n/c | 1 | SEC ↗ ×22 |
| 3 | State Street Global Advisors ✦ (被动) | 2.93M | -2.2% | $554.24M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.17M | +6.6% | $409.99M | 0.1% | ▲ Add | 5 | SEC ↗ ×8 |
| 5 | Geode Capital Management ✦ (被动) | 1.78M | -3.9% | $336.48M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 1.67M | +3.9% | $316.85M | 0.3% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Fidelity (FMR) ✦ | 1.34M | n/a | $254.51M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 8 | Capital World Investors ✦ | 1.30M | +3.6% | $245.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Norges Bank ✦ (被动) | 820.24K | -6.6% | $155.30M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Millennium Management ✦ | 753.49K | -16.0% | $142.66M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 532.14K | +31.6% | $100.75M | 0.1% | ▲ Add | 5 | SEC ↗ ×5 |
| 12 | Adage Capital Partners ✦ | 161.81K | +27.0% | $30.64M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 101.65K | +0.4% | $19.25M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 14 | Arrowstreet Capital ✦ | 63.50K | +189.1% | $12.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 60.25K | +43.4% | $11.41M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 16 | Fisher Asset Management ✦ | 52.89K | -8.1% | $10.01M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | ARK Investment Management ✦ | 6.21K | +3.7% | $1.17M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 2.26K | -23.8% | $428,454 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 2.10K | 新增 | $397,593 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Renaissance Technologies | $397,593 | 0.0% |
已清仓
| Marshall Wace | $35.03M | 曾为 0.0% |
| D. E. Shaw & Co. | $3.88M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 680 持有人, 68.43M 股份, $11.46B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据